MEREDITH OVERSTREET: Open Payments
NPI 1699287946 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 33 payments from 11 companies in 2025. Trend: 2023 $1,094 · 2024 $523 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $233 |
| Collegium Pharmaceutical, Inc. | 12 | $188 |
| Medtronic, Inc. | 1 | $153 |
| Boston Scientific Corporation | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| SCILEX PHARMACEUTICALS INC. | 2 | $46 |
| Lundbeck LLC | 1 | $29 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
Products named: QULIPTA, INTELLIS ADAPTIVESTIM, Belbuca, XTAMPZA, WaveWriter Alpha Prime 16, RELISTOR, ZTLido, VYEPTI.
Industry payments across VA — which companies pay providers there.
